Compare APOG & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | APOG | IRMD |
|---|---|---|
| Founded | 1949 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 820.9M | 910.4M |
| IPO Year | N/A | 2014 |
| Metric | APOG | IRMD |
|---|---|---|
| Price | $38.79 | $97.18 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $47.00 | ★ $72.00 |
| AVG Volume (30 Days) | ★ 156.6K | 84.1K |
| Earning Date | 01-07-2026 | 11-03-2025 |
| Dividend Yield | ★ 2.58% | 0.72% |
| EPS Growth | N/A | ★ 13.00 |
| EPS | ★ 2.05 | 1.65 |
| Revenue | ★ $1,391,854,000.00 | $80,511,268.00 |
| Revenue This Year | $5.66 | $15.17 |
| Revenue Next Year | $0.83 | $10.15 |
| P/E Ratio | ★ $19.60 | $58.39 |
| Revenue Growth | 1.19 | ★ 12.91 |
| 52 Week Low | $32.77 | $47.48 |
| 52 Week High | $76.72 | $98.44 |
| Indicator | APOG | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.96 | 67.41 |
| Support Level | $39.78 | $93.06 |
| Resistance Level | $41.00 | $98.37 |
| Average True Range (ATR) | 1.02 | 2.42 |
| MACD | 0.21 | -0.38 |
| Stochastic Oscillator | 50.47 | 82.45 |
Apogee Enterprises Inc is a provider of architectural products and services for enclosing buildings, and high-performance glass and acrylic products used in applications for preservation, protection, and enhanced viewing. The company's operating segment consists of the Architectural Metals Segment, Architectural Services Segment, Architectural Glass Segment, and Performance Surfaces Segment. The company generates the majority of its revenue from the Architectural Metals Segment, which designs, engineers, fabricates, and finishes aluminum window, curtainwall, storefront, and entrance systems used principally in non-residential construction. The company generates revenue geographically from the United States, Canada, and Brazil, with the majority coming from the United States.
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.